Today: 8 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Micron stock jumps again as DRAM squeeze talk returns — and Feb. 11 is the next test

Micron stock jumps again as DRAM squeeze talk returns — and Feb. 11 is the next test

Micron shares jumped 6% to $435.28 in early U.S. trading Thursday after Samsung and SK Hynix warned of tightening DRAM supply. Both companies said chipmakers are shifting production toward AI-focused memory, leaving PC and smartphone makers struggling to secure DRAM. Micron executives are set to speak at a Wolfe Research conference on Feb. 11. The Federal Reserve held rates steady Wednesday, offering no guidance on future cuts.
Meta stock jumps about 9% as Zuckerberg bets big on “superintelligence” spending

Meta stock jumps about 9% as Zuckerberg bets big on “superintelligence” spending

Meta shares rose 9.3% to $731.18 in early U.S. trading after reporting Q4 revenue up 24% to $59.89 billion and issuing a strong revenue forecast. The company raised its 2026 capital spending target to as much as $135 billion, citing major investments in AI. Costs jumped 40%, cutting operating margin to 41%. Meta projects full-year 2026 expenses up to $169 billion, warning of legal and regulatory risks.
Intel stock price slips after report-driven rally; Nvidia-Apple foundry chatter keeps INTC in focus

Intel stock price slips after report-driven rally; Nvidia-Apple foundry chatter keeps INTC in focus

Intel shares fell 2.5% to $47.54 in early New York trading Thursday, reversing an 11% surge on speculation of future foundry deals with Nvidia and Apple. CFO David Zinsner bought 5,882 shares at $42.50 each on Jan. 26, SEC filings show. Chip sector sentiment stayed firm after ASML posted record quarterly bookings. Investors are now watching Friday’s U.S. inflation data.
Apple stock slips as earnings loom; iPhone sales and Siri AI push in sharp focus

Apple stock slips as earnings loom; iPhone sales and Siri AI push in sharp focus

Apple shares fell 0.7% to $256.44 in early New York trading Thursday ahead of quarterly earnings due after the bell. Investors are focused on iPhone sales, rising memory costs, and updates to Siri using Google’s AI. Analysts expect record revenue and the strongest iPhone growth in four years, led by China demand. Regulatory scrutiny of Apple’s services continues.
Tesla stock steadies after Musk’s $2 billion xAI bet and a $20 billion spending jolt

Tesla stock steadies after Musk’s $2 billion xAI bet and a $20 billion spending jolt

Tesla shares edged up 0.07% to $431.46 in early Thursday trading after volatile moves on earnings and spending plans. The company reported 2025 revenue down 3% to $94.83 billion and confirmed a $2 billion investment in xAI. Tesla reaffirmed Cybercab robotaxi production is on track for 2026, with Gen 3 Optimus and Tesla Semi launches planned for the same period. Investors are watching cash burn and regulatory hurdles.
Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher shares fell 2.55% to $608.02 Wednesday, their second straight decline ahead of Thursday’s Q4 earnings call. Trading volume topped 2.3 million, above average, as investors weighed Danaher’s warning on weak academic research funding. The stock now sits 5.6% below its Jan. 22 high. Life-science tools stocks broadly declined during the session.
Elevance Health stock rebounds nearly 6% after earnings — here’s what matters before Thursday’s trade

Elevance Health stock rebounds nearly 6% after earnings — here’s what matters before Thursday’s trade

Elevance Health shares rose 5.9% to $341.85 Wednesday after plunging 14% the previous session. The insurer projected 2026 adjusted earnings of at least $25.50 per share, below analyst forecasts, and expects a small revenue decline. Fourth-quarter operating revenue rose 10% to $49.3 billion. Medicare Advantage payment changes and rising medical costs continue to drive volatility in managed-care stocks.
Uber stock drops 1.8% — Waabi robotaxi deal and Dutch driver ruling set up earnings test

Uber stock drops 1.8% — Waabi robotaxi deal and Dutch driver ruling set up earnings test

Uber shares fell 1.8% to $79.78 Wednesday, underperforming a flat S&P 500. A Dutch court ruled Uber drivers can be classified as self-employed, reversing a 2021 decision. Uber pledged up to $250 million to Waabi, aiming to deploy at least 25,000 robotaxis on its platform. Investors weighed regulatory and automation developments ahead of Uber’s Feb. 4 earnings report.
Abbott stock slides after CEO’s $2 million buy hits SEC filing — what investors watch next

Abbott stock slides after CEO’s $2 million buy hits SEC filing — what investors watch next

Abbott shares fell 2.1% to $106.05 Wednesday after CEO Robert Ford bought about $2 million in stock through a family trust, according to an SEC filing. The stock has dropped 12% in five sessions following a disappointing earnings report and a price target cut by Argus. Investors are watching for updates at major medical conferences starting Jan. 29 in New Orleans.
29 January 2026
Chevron stock rises as Reuters reports March surge in Venezuelan crude exports to U.S.

Chevron stock rises as Reuters reports March surge in Venezuelan crude exports to U.S.

Chevron shares rose 0.5% to $169.91 Wednesday after Reuters reported the company plans to boost Venezuelan crude exports to about 300,000 barrels per day in March. Oil prices climbed over 1%, lifting energy stocks and sending the S&P 500 energy sector up 0.7%. Chevron traded between $168.20 and $170.42 on 6.8 million shares. Investors await Chevron’s earnings and outlook Friday.
29 January 2026
1 166 167 168 169 170 690
Go toTop